Presentation ACC 2024 Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC) Presenter: Rasha K. Al-Lamee April 08, 2024 REGISTER for free or LOG IN to view this content Clinical Cardiology Clinical Pharma Coronary CAD Pharma ACS/AMI Vascular Access/Closure Policy & Practice Cath Lab Presentation ACC 2024 Up Next Presentation ACC 2024 Comparison of IVUS-guided vs. Angiography-guided Angioplasty for the Outcomes of DCB in the Treatment of Femoropopliteal Artery Disease Presenter: Young-Guk Ko April 08, 2024 More slides + Presentation Fellows 2024 ACS PCI Case: Loading, Timing, Transitions, and Other Issues Presenter: Binita Shah April 13, 2024 Presentation Fellows 2024 Challenging Structural Cases With Discussion Presenter: Torsten P. Vahl April 13, 2024 We Recommend
Presentation ACC 2024 Comparison of IVUS-guided vs. Angiography-guided Angioplasty for the Outcomes of DCB in the Treatment of Femoropopliteal Artery Disease Presenter: Young-Guk Ko April 08, 2024
Presentation Fellows 2024 ACS PCI Case: Loading, Timing, Transitions, and Other Issues Presenter: Binita Shah April 13, 2024
Presentation Fellows 2024 Challenging Structural Cases With Discussion Presenter: Torsten P. Vahl April 13, 2024